tiprankstipranks
Trending News
More News >
Summit Therapeutics Announces Positive Phase III Trial Results
PremiumCompany AnnouncementsSummit Therapeutics Announces Positive Phase III Trial Results
8d ago
Summit Therapeutics jumps 13% to $29.79 after results from HARMONi trial
Premium
The Fly
Summit Therapeutics jumps 13% to $29.79 after results from HARMONi trial
9d ago
Summit Therapeutics announces topline results from Phase 3 HARMONi trial
Premium
The Fly
Summit Therapeutics announces topline results from Phase 3 HARMONi trial
9d ago
Summit Therapeutics initiated with a Buy at TD Cowen
PremiumThe FlySummit Therapeutics initiated with a Buy at TD Cowen
1M ago
Summit Therapeutics’ Ivonescimab: A Potential Game-Changer in NSCLC Treatment with Promising HARMONi Trial Results
Premium
Ratings
Summit Therapeutics’ Ivonescimab: A Potential Game-Changer in NSCLC Treatment with Promising HARMONi Trial Results
1M ago
BioNTech price target lowered to $132 from $140 at Morgan Stanley
Premium
The Fly
BioNTech price target lowered to $132 from $140 at Morgan Stanley
1M ago
Summit Therapeutics Reports Q1 2025 Progress and Financials
PremiumCompany AnnouncementsSummit Therapeutics Reports Q1 2025 Progress and Financials
1M ago
Summit Therapeutics Reports Q1 2025 Financial Results
Premium
Company Announcements
Summit Therapeutics Reports Q1 2025 Financial Results
1M ago
Summit Therapeutics reports Q1 adjusted EPS (7c), consensus (7c)
Premium
The Fly
Summit Therapeutics reports Q1 adjusted EPS (7c), consensus (7c)
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100